ArticleBMJ open2026
Association of poor sleep quality with adverse glycaemic outcomes in Chinese Itadults with type 2 diabetes: a family-based cohort study.
Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo examine the association between baseline sleep quality and subsequent glycaemic outcomes in adults with type 2 diabetes mellitus (T2DM), using repeated fasting blood glucose measurements and longitudinal glycaemic pattern analyses.
designProspective cohort study.
settingThe Taizhou Diabetes Family-based Cohort in Zhejiang Province, China.
participantsA total of 1421 adults with T2DM with baseline sleep quality assessment and follow-up fasting blood glucose measurements were included.
main outcome measuresBaseline sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI). Follow-up fasting blood glucose measurements were obtained through 30 June 2025. The primary outcomes were continuous fasting blood glucose levels and binary fasting blood glucose status defined as ≥7.0 mmol/L during follow-up. Secondary outcomes included glycaemic variability and latent glycaemic trajectory classes.
resultsPoorer baseline sleep quality was associated with less favourable glycaemic outcomes during follow-up. In the fully adjusted model, each 1-point increase in PSQI score was associated with a 0.096 mmol/L higher fasting blood glucose level (95% CI 0.081 to 0.111), and poor sleep quality was associated with a 0.669 mmol/L higher fasting blood glucose level (95% CI 0.547 to 0.791). For the binary outcome, each 1-point increase in PSQI score was associated with higher odds of fasting blood glucose ≥7.0 mmol/L (OR 1.10, 95% CI 1.08 to 1.12), and poor sleep quality was associated with 1.61-fold higher odds of fasting blood glucose ≥7.0 mmol/L (95% CI 1.37 to 1.91). Higher PSQI scores were also associated with greater glycaemic variability and higher odds of membership in less favourable glycaemic trajectory groups.
conclusionsAmong adults with T2DM, poorer baseline sleep quality was associated with higher fasting blood glucose levels, poorer glycaemic control, greater glycaemic variability and less favourable long-term glycaemic trajectories. These findings suggest that sleep quality may be a relevant and easily assessable marker for identifying individuals at risk of suboptimal long-term glycaemic management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.